Unraveling the Challenges: Comprehensive Approach to Management of Oligoprogression in Breast Cancer
On behalf of Memorial Sloan Kettering Cancer Center (MSK), our India Center team invites you to MSK’s next oncology tumor board scheduled for Wednesday, 11 October 2023.
Memorial Sloan Kettering Cancer (MSK) in New York proudly presents educational programs for current and future physicians and scientists. Through this interactive series, we look to accelerate the exchange of knowledge to improve patient outcomes, foster new research collaborations, and increase graduate and post-graduate training exchange. The focus of our next event will be on the management of oligoprogression in breast cancer.
The tumor board series will be directed by Dr. Jasmeet C. Singh and Dr. Andrew D. Seidman of MSK and Dr. Atul Batra of AIIMS, India.
Tumor board moderated by Dr. Jasmeet C. Singh, MSK, New York and Dr. Andrew D. Seidman, MSK, New York of MSK and Dr. Atul Batra of AIIMS, India.
Dr. Emanuela Ferraro, Memorial Sloan Kettering and Dr. Aastha Goel, AIIMS, India
Dr. Akash Jha, AIIMS, India and Dr. Supriya Mallick, AIIMS, India
Dr. Nelson Moss, Memorial Sloan Kettering and Dr. Krithika Rangarajan, AIIMS, India
Dr. Robert Young, Memorial Sloan Kettering